Abstract PD1-03: Estrogen receptor is a target of enzalutamide in ER+ breast cancer
Year: 2022
Type: conference-abstract
Source: Cancer Research
Institution: Mayo Clinic
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4220801907
